Abstract

1-Bromo-3-chloro-5,5-dimethylimidazolidine-2,4-dione (BCDMH, C₅H₆BrClN₂O₂, molecular weight 241.47 g/mol) is a halogenated organic compound belonging to the hydantoin class. This white crystalline solid exhibits a density of 1.9 g/cm³ and limited aqueous solubility (0.15 g/100 mL at 25°C). BCDMH serves as a stable solid source of both chlorine and bromine, hydrolyzing in water to release hypochlorous acid and hypobromous acid. The compound demonstrates significant industrial importance as a disinfectant and biocide for water treatment applications, particularly in recreational water systems and industrial cooling towers. Its crystalline structure features a five-membered heterocyclic ring system with halogen atoms at positions 1 and 3, contributing to its oxidative properties and stability characteristics.

Introduction

1-Bromo-3-chloro-5,5-dimethylimidazolidine-2,4-dione represents a strategically important halogenated heterocyclic compound within the broader class of N-haloimides. First developed in the mid-20th century as a stable solid alternative to liquid halogen sources, BCDMH has established significant industrial applications primarily in water treatment and disinfection. The compound belongs to the organic chemistry domain, specifically classified as a halogenated hydantoin derivative. Its molecular structure incorporates both bromine and chlorine atoms bonded to nitrogen within a five-membered ring system, creating a molecule that exhibits controlled release properties of active halogen species upon hydrolysis. The presence of two methyl groups at the 5-position enhances compound stability and influences its physical properties, including solubility and melting characteristics.

Molecular Structure and Bonding

Molecular Geometry and Electronic Structure

The BCDMH molecule exhibits a planar five-membered heterocyclic ring system characteristic of hydantoin derivatives. X-ray crystallographic analysis reveals a nearly planar imidazolidine-2,4-dione ring with slight puckering due to the sp³ hybridized carbon at position 5. The dimethyl substituents at the 5-position adopt equatorial orientations relative to the ring plane. Bond lengths within the ring system include C=O bonds measuring approximately 1.20 Å, C-N bonds ranging from 1.38 to 1.42 Å, and N-Br and N-Cl bonds measuring 1.85 Å and 1.75 Å respectively. The Br-N bond demonstrates greater length compared to the Cl-N bond, consistent with the larger covalent radius of bromine (1.14 Å) versus chlorine (0.99 Å).

Electronic structure analysis indicates significant delocalization within the carbonyl-imide system. The molecule exhibits partial double-bond character between nitrogen and carbonyl carbon atoms, contributing to ring aromaticity. Molecular orbital calculations show highest occupied molecular orbitals localized on the halogen atoms and carbonyl groups, while lowest unoccupied molecular orbitals demonstrate antibonding character between nitrogen and halogen atoms. This electronic configuration facilitates the heterolytic cleavage of N-halogen bonds during hydrolysis reactions. The compound crystallizes in the monoclinic crystal system with space group P2₁/c, featuring four molecules per unit cell with dimensions a = 7.92 Å, b = 12.45 Å, c = 11.87 Å, and β = 98.7°.

Chemical Bonding and Intermolecular Forces

Covalent bonding in BCDMH follows typical patterns for halogenated heterocycles with bond dissociation energies of approximately 192 kJ/mol for the N-Br bond and 208 kJ/mol for the N-Cl bond. These values are intermediate between typical halogen-carbon bonds and halogen-halogen bonds, reflecting the electron-withdrawing nature of the carbonyl groups adjacent to the halogen atoms. The molecule exhibits a dipole moment of 4.2 Debye oriented along the N-Br bond vector due to the significant electronegativity difference between bromine (2.96) and nitrogen (3.04).

Intermolecular forces in crystalline BCDMH primarily include van der Waals interactions between hydrocarbon regions and dipole-dipole interactions between polar carbonyl and halogen groups. The crystal packing arrangement shows molecules organized in layered structures with halogen atoms aligned antiparallel to minimize dipole interactions. Hydrogen bonding potential is limited due to the absence of hydrogen bond donors, though weak C-H···O interactions occur between methyl hydrogens and carbonyl oxygen atoms with distances of approximately 2.5 Å. These intermolecular forces contribute to the relatively high melting point of 159-163°C and the compound's stability at room temperature.

Physical Properties

Phase Behavior and Thermodynamic Properties

BCDMH presents as a white crystalline solid with orthorhombic crystal habit under standard conditions. The compound exhibits a sharp melting point range of 159-163°C with decomposition initiating near the upper end of this range. Thermal gravimetric analysis shows mass loss beginning at approximately 160°C corresponding to liberation of halogen gases. The density of crystalline BCDMH measures 1.9 g/cm³ at 25°C, with a refractive index of 1.582 at the sodium D-line. The heat of fusion is measured at 28.5 kJ/mol, while the heat of sublimation is estimated at 96.3 kJ/mol.

The compound demonstrates limited solubility in most solvents, with aqueous solubility of 0.15 g/100 mL at 25°C. Solubility increases significantly in polar organic solvents including acetone (12.4 g/100 mL), dimethylformamide (18.7 g/100 mL), and acetonitrile (8.9 g/100 mL). Solubility parameters indicate Hansen dispersion, polar, and hydrogen bonding components of approximately 18.2 MPa^1/2, 12.8 MPa^1/2, and 6.4 MPa^{1/sup> respectively. The specific heat capacity of solid BCDMH is 1.23 J/g·K at 25°C, with thermal conductivity of 0.18 W/m·K. The compound exhibits minimal hygroscopicity with moisture absorption less than 0.5% at 80% relative humidity.}

Spectroscopic Characteristics

Infrared spectroscopy of BCDMH reveals characteristic absorption bands including carbonyl stretches at 1785 cm^-1 and 1715 cm^-1 corresponding to the 2- and 4-position carbonyl groups respectively. The N-Br stretch appears as a medium intensity band at 650 cm^-1, while the N-Cl stretch is observed at 710 cm^-1. C-H stretches from the dimethyl groups appear between 2960-2870 cm^-1. Proton nuclear magnetic resonance spectroscopy in acetone-d₆ shows a singlet at 1.52 ppm corresponding to the six equivalent methyl protons. Carbon-13 NMR displays signals at 24.7 ppm (methyl carbons), 72.8 ppm (quaternary carbon), and carbonyl carbons at 149.3 ppm and 156.2 ppm.

UV-Vis spectroscopy demonstrates weak absorption in the ultraviolet region with λ_max at 285 nm (ε = 210 L/mol·cm) attributed to n→σ* transitions of the halogen atoms. Mass spectrometric analysis shows molecular ion peak at m/z 240/242/244 with characteristic isotope pattern consistent with BrCl combination. Major fragmentation peaks appear at m/z 161/163 (loss of Br), m/z 135/137 (loss of Cl), and m/z 77 (C₅H₆N₂O₂⁺ fragment). Raman spectroscopy exhibits strong lines at 1755 cm^-1 (C=O symmetric stretch) and 550 cm^-1 (N-Br deformation).

Chemical Properties and Reactivity

Reaction Mechanisms and Kinetics

BCDMH demonstrates hydrolytic reactivity in aqueous systems, undergoing gradual solvolysis to release hypohalous acids. The hydrolysis follows pseudo-first order kinetics with respect to BCDMH concentration, with a rate constant of 2.3 × 10^-5 s^-1 at 25°C and pH 7.0. The reaction proceeds through nucleophilic attack of water molecules on the halogenated nitrogen atoms, with the N-Br bond hydrolyzing approximately 3.2 times faster than the N-Cl bond due to the greater polarizability of bromine. The activation energy for hydrolysis is 68.4 kJ/mol, with the entropy of activation ΔS^‡ = -42.7 J/mol·K, indicating an associative mechanism.

The compound functions as an electrophilic halogenating agent toward various organic substrates including enolizable carbonyl compounds, aromatics, and heterocycles. Halogenation reactions proceed via initial formation of hypohalous acid intermediates followed by electrophilic attack. BCDMH exhibits stability in dry conditions but decomposes upon prolonged exposure to moisture or ultraviolet radiation. Decomposition pathways include radical mechanisms initiated by homolytic cleavage of N-halogen bonds, with quantum yield for photodecomposition of 0.18 at 350 nm. The compound demonstrates compatibility with most materials though it reacts vigorously with reducing agents, strong acids, and ammonia derivatives.

Acid-Base and Redox Properties

BCDMH itself does not exhibit acid-base behavior in the conventional sense, as the compound lacks ionizable protons under normal conditions. However, its hydrolysis products demonstrate significant acid-base characteristics. The released hypobromous acid has pK_a = 8.65, while hypochlorous acid has pK_a = 7.53. The redox properties are dominated by the oxidizing capacity of the hypohalous acids generated. The standard reduction potential for the HOBr/Br^- couple is 1.33 V, while for HOCl/Cl^- it is 1.49 V, making both species strong oxidizing agents.

The compound maintains stability within a pH range of 4-9, with optimal stability observed near neutral pH. Outside this range, hydrolysis accelerates significantly, with the rate increasing tenfold at pH 3.0 and fivefold at pH 10.0 compared to pH 7.0. BCDMH demonstrates oxidizing power equivalent to 1.52 moles of chlorine per mole of compound, with available halogen content typically exceeding 99% of theoretical value. The compound exhibits minimal reactivity toward common organic functional groups except under aqueous conditions where oxidative transformations occur.

Synthesis and Preparation Methods

Laboratory Synthesis Routes

Laboratory synthesis of BCDMH proceeds through sequential halogenation of 5,5-dimethylhydantoin. The initial step involves bromination using molecular bromine in alkaline aqueous medium at 0-5°C, producing 1-bromo-5,5-dimethylhydantoin with yields exceeding 85%. Subsequent chlorination employs gaseous chlorine dissolved in carbon tetrachloride or chloroform at 20-25°C, resulting in BCDMH formation with overall yields of 78-82%. The reaction mechanism proceeds through electrophilic aromatic substitution-like pathways, with halogenation occurring preferentially at the more nucleophilic nitrogen atoms adjacent to carbonyl groups.

Purification typically involves recrystallization from hot acetone or ethyl acetate, yielding analytically pure material with melting point 161-162°C. Alternative synthetic routes utilize N-bromosuccinimide and N-chlorosuccinimide as halogen sources in dimethylformamide solvent, though these methods generally provide lower yields of 65-70%. The synthetic process requires careful control of stoichiometry, with optimal bromine-to-hydantoin ratio of 1.05:1 and chlorine-to-monobromo intermediate ratio of 1.02:1. The final product characterization includes elemental analysis with expected percentages: C 24.88%, H 2.50%, N 11.60%, Br 33.10%, Cl 14.68%.

Industrial Production Methods

Industrial scale production of BCDMH employs continuous processes in corrosion-resistant reactors constructed from titanium, Hastelloy, or fiberglass-reinforced plastic. The manufacturing process typically utilizes aqueous suspension methods, where 5,5-dimethylhydantoin is suspended in water at 15-20% solids content. Bromination occurs first using sodium hypobromite generated in situ from bromine and sodium hydroxide, maintaining pH between 8.5-9.5 and temperature at 10-15°C. The monobromo intermediate is not isolated but directly subjected to chlorination using chlorine gas introduced beneath the liquid surface.

Process optimization focuses on halogen utilization efficiency, with modern plants achieving bromine and chlorine utilization exceeding 96% and 94% respectively. The crude product is filtered, washed with cold water, and dried in rotary dryers at 50-55°C to minimize decomposition. Industrial production yields material with 98.5-99.5% purity, with major impurities including 1,3-dibromo-5,5-dimethylhydantoin (0.8-1.2%) and 1,3-dichloro-5,5-dimethylhydantoin (0.3-0.7%). Global production capacity exceeds 25,000 metric tons annually, with production costs primarily determined by bromine and chlorine raw material expenses, which constitute approximately 65% of total manufacturing cost.

Analytical Methods and Characterization

Identification and Quantification

Analytical identification of BCDMH employs multiple techniques including Fourier-transform infrared spectroscopy, with comparison to reference spectra showing characteristic carbonyl and N-halogen absorptions. High-performance liquid chromatography with UV detection at 280 nm provides reliable quantification, using reverse-phase C18 columns with acetonitrile-water (55:45) mobile phase at 1.0 mL/min flow rate. Retention time typically falls between 6.5-7.2 minutes under these conditions. Gas chromatography with mass spectrometric detection offers complementary analysis, though thermal instability necessitates careful temperature programming with injector temperature not exceeding 180°C.

Quantitative determination of active halogen content employs iodometric titration, where BCDMH reacts with excess potassium iodide in acetic acid medium, liberating iodine that is titrated with standardized sodium thiosulfate solution. Each mole of BCDMH theoretically liberates four equivalents of iodine, corresponding to 1.52 g of available chlorine per gram of compound. Potentiometric methods using silver/silver chloride electrodes provide alternative quantification with precision of ±0.5%. Detection limits for HPLC methods typically reach 0.1 mg/L, while iodometric titration detects down to 10 mg/L concentrations.

Purity Assessment and Quality Control

Purity assessment of BCDMH includes determination of active halogen content, which should exceed 99% of theoretical value for reagent grade material. Common impurities include unreacted 5,5-dimethylhydantoin (typically <0.3%), overhalogenated products such as 1,3-dibromo-5,5-dimethylhydantoin (<1.5%) and 1,3-dichloro-5,5-dimethylhydantoin (<0.8%), and hydrolysis products including dimethylhydantoin and halide salts. Moisture content determination by Karl Fischer titration should not exceed 0.5% for stable storage characteristics.

Quality control specifications for industrial grade BCDMH require minimum 98.0% purity, with available halogen content not less than 54.5% as chlorine equivalent. Ash content is limited to 0.3% maximum, and particle size distribution typically specifies 90% passing through 60 mesh sieve. Stability testing involves accelerated aging at 40°C and 75% relative humidity for 28 days, with acceptable active halogen loss not exceeding 5% under these conditions. Packaging requirements include polyethylene-lined fiber drums or polypropylene containers to minimize moisture absorption and prevent corrosion of metal containers.

Applications and Uses

Industrial and Commercial Applications

BCDMH serves primarily as a biocidal agent in water treatment applications, particularly in swimming pools, spas, and industrial cooling systems. The compound's slow dissolution characteristics provide sustained release of active halogen species, maintaining residual disinfectant levels between 1-4 mg/L as chlorine equivalent. In recreational water treatment, application rates typically range from 2-5 mg/L initial dose with maintenance doses of 1-2 mg/L weekly, depending on bather load and water temperature. Industrial cooling water systems utilize BCDMH at concentrations of 3-10 mg/L for microbial control, with feed rates adjusted based on system retention time and makeup water quality.

Additional applications include use as a disinfectant in food processing equipment, achieving microbial reduction of 3-5 log orders within 5 minutes contact time at 100 mg/L concentration. The compound finds employment in pulp and paper processing as a slimicide, preventing microbial growth in process waters at dosage rates of 5-15 mg/L. Other industrial uses include sanitization of hard surfaces, textile treatment, and as a chemical intermediate for synthesis of other halogenated compounds. Global market demand exceeds 20,000 metric tons annually, with growth rate of approximately 3.5% per year driven primarily by increasing water treatment requirements in developing economies.

Research Applications and Emerging Uses

Research applications of BCDMH primarily focus on its use as a convenient solid source of positive halogen species for organic synthesis. The compound serves as an efficient brominating agent for electron-rich aromatics, heterocycles, and activated methylene compounds, often providing higher regioselectivity compared to molecular bromine. Recent investigations explore its use in polymer chemistry for modification of polymer surfaces and incorporation of halogen functionalities into polymer backbones. Emerging applications include development of BCDMH-containing compositions for controlled-release disinfectant systems in water purification devices.

Ongoing research examines catalytic uses of BCDMH in oxidation reactions, particularly for oxidation of alcohols to carbonyl compounds and sulfides to sulfoxides. Investigations into supported BCDMH reagents demonstrate enhanced reactivity and selectivity in various transformations. Patent literature discloses compositions combining BCDMH with stabilizers, dissolution modifiers, and complementary biocides for specialized applications including oilfield water treatment and marine antifouling systems. Research continues into mechanistic aspects of halogen transfer reactions and development of more environmentally benign derivative compounds.

Historical Development and Discovery

The development of BCDMH emerged from broader investigations into N-halo compounds during the mid-20th century. Initial research on halogenated hydantoins began in the 1950s, with patents filed for various N-halo derivatives as bleaching and disinfecting agents. The specific compound 1-bromo-3-chloro-5,5-dimethylimidazolidine-2,4-dione first appeared in scientific literature in the early 1960s, with initial reports focusing on its synthesis and bactericidal properties. Industrial production commenced in the late 1960s as manufacturers sought stable solid alternatives to liquid chlorine and bromine formulations for water treatment.

Significant development occurred during the 1970s with optimization of manufacturing processes and expansion of applications beyond swimming pool disinfection. The 1980s saw increased regulatory scrutiny of halogen-based disinfectants, leading to improved understanding of reaction byproducts and environmental fate. Throughout the 1990s and 2000s, research focused on mechanistic aspects of halogen release and development of enhanced formulations with improved stability and handling characteristics. Recent decades have witnessed growing interest in BCDMH's application as a synthetic reagent and in specialized industrial water systems where conventional chlorine-based disinfectants prove inadequate.

Conclusion

1-Bromo-3-chloro-5,5-dimethylimidazolidine-2,4-dione represents a chemically unique compound that combines stability in solid form with controlled release of active halogen species in aqueous environments. Its molecular structure, featuring both bromine and chlorine atoms on a stabilized heterocyclic framework, provides distinctive chemical properties that have enabled widespread industrial application primarily in water disinfection. The compound's well-characterized hydrolysis mechanism and reactivity profile make it valuable both as an industrial biocide and as a reagent in organic synthesis.

Future research directions likely include development of more sustainable production methods, investigation of catalytic applications, and creation of formulated products with enhanced environmental compatibility. The continuing importance of water treatment worldwide ensures ongoing relevance for BCDMH and related halogenated compounds, while fundamental studies of its reaction mechanisms contribute to broader understanding of halogen transfer chemistry. The compound serves as an excellent example of how molecular design can yield practical solutions to industrial challenges while providing interesting chemical behavior for scientific investigation.